Eli Lilly

$149.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.75 (-3.08%) As of 3:16 PM EDT today

Why Robinhood?

You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. Read More The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Employees
33,625
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
143.47B
Price-Earnings Ratio
25.08
Dividend Yield
1.86
Average Volume
4.87M
High Today
$153.66
Low Today
$149.08
Open Price
$153.40
Volume
2.19M
52 Week High
$170.75
52 Week Low
$101.36

Collections

LLY News

BenzingaSep 18

A Look Into Eli Lilly's Debt

Over the past three months, shares of Eli Lilly (NYSE: LLY) moved lower by 4.31%. Before we understand the importance of debt, let us look at how much debt Eli
CNBCSep 17

Lilly and Amgen partner to manufacture potential coronavirus drugs

Eli Lilly has partnered with Amgen to increase the capacity of its experimental Covid-19 antibody treatments, a day after one of the drugs was shown to reduce t
MarketWatchSep 17

Eli Lilly and Amgen to collaborate on COVID-19 antibody therapies

Eli Lilly and Co. LLY, +0.58% and Amgen Inc. AMGN, -0.23% said Thursday they will collaborate on COVID-19 antibody treatments as a way to significantly boost gl

LLY Earnings

$0.00
$0.63
$1.26
$1.89
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Oct 27, Pre-Market

You May Also Like

More LLY News

CNBCSep 16

Jim Cramer on Eli Lilly's Covid-19 phase 2 trial results for antibody drug

Jim Cramer on Eli Lilly's Covid-19 phase 2 trial results for antibody drug Eli Lilly announced on Wednesday it had found proof of concept data from an interim
New York TimesSep 16

An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims

A single infusion of an experimental drug has markedly reduced blood levels of the coronavirus in newly infected patients and lowered the chances that they woul
ReutersSep 16

Lilly says antibody reduces need for hospitalization for moderate COVID-19 patients

(Reuters) - Eli Lilly & Co said on Wednesday that its experimental antibody reduced the need for hospitalization and emergency room visits for patients with mod
CNBCSep 16

Eli Lilly reports a reduced rate of hospitalization for coronavirus patients using its antibody treatment

In this May 2020 photo provided by Eli Lilly, researchers prepare mammalian cells to produce possible COVID-19 antibodies for testing in a laboratory in Indiana
ReutersSep 15

Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, Febru
BenzingaSep 14

Gilead, Pfizer, Eli Lilly CEOs On COVID-19 Treatments, Vaccine Development

Major coronavirus treatments and vaccine maker executives were interviewed on CNBC Monday to discuss their company's progress in the battle against the disease.
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.